4//SEC Filing
Hindman Andrew A. 4
Accession 0001179110-20-009265
CIK 0001583107other
Filed
Aug 23, 8:00 PM ET
Accepted
Aug 24, 6:24 PM ET
Size
4.5 KB
Accession
0001179110-20-009265
Insider Transaction Report
Form 4
Hindman Andrew A.
SVP, Chief Financial Officer
Transactions
- Tax Payment
Ordinary Shares
2020-08-20$18.22/sh−4,323$78,765→ 123,135 total
Documents
Issuer
Theravance Biopharma, Inc.
CIK 0001583107
Entity typeother
Related Parties
1- filerCIK 0001607965
Filing Metadata
- Form type
- 4
- Filed
- Aug 23, 8:00 PM ET
- Accepted
- Aug 24, 6:24 PM ET
- Size
- 4.5 KB